Amgen
AMGN
$269.98
Share price
0.22%
Change (1 day)
13.06%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
EPS for Amgen (AMGN)
EPS in 2023 (TTM): $14.15
According to Amgen's latest financial reports the company's current EPS (TTM) is $14.15. In 2022 the company made an earnings per share (EPS) of $12.18 an increase over its 2021 EPS that were of $10.36.
EPS history for Amgen from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $14.15 | 16.17% |
| 2022 | $12.18 | 17.57% |
| 2021 | $10.36 | -16.38% |
| 2020 | $12.39 | -4.32% |
| 2019 | $12.95 | 2.05% |
| 2018 | $12.69 | 382.51% |
| 2017 | $2.63 | -74.52% |
| 2016 | $10.32 | 12.66% |
| 2015 | $9.16 | 34.9% |
| 2014 | $6.79 | 0.74% |
| 2013 | $6.74 | 20.36% |
| 2012 | $5.60 | 37.93% |
| 2011 | $4.06 | -15.77% |
| 2010 | $4.82 | 6.4% |
| 2009 | $4.53 | 19.84% |
| 2008 | $3.78 | 35% |
| 2007 | $2.80 | 12% |
| 2006 | $2.50 | -15.54% |
| 2005 | $2.96 | 59.14% |
| 2004 | $1.86 | 6.9% |
| 2003 | $1.74 | -289.13% |
| 2002 | -$0.92 | -186.79% |
| 2001 | $1.06 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -0.46% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | -86.86% | 🇺🇸 USA |
 AbbVie ABBV | $3.68 | -73.99% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | -61.63% | 🇺🇸 USA |
 Biogen BIIB | $18.46 | 30.46% | 🇺🇸 USA |
 Gilead Sciences GILD | $4.39 | -68.98% | 🇺🇸 USA |
 Illumina ILMN | -$26.61 | -288.06% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -71.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -75.26% | 🇬🇧 UK |